Copyright
©The Author(s) 2005.
World J Gastroenterol. Jul 7, 2005; 11(25): 3817-3822
Published online Jul 7, 2005. doi: 10.3748/wjg.v11.i25.3817
Published online Jul 7, 2005. doi: 10.3748/wjg.v11.i25.3817
Table 2 RCT studies on efficacy of systemic chemotherapy on prevention of recurrence
| Authors | Treatment protocol | Sample size(Tx/Ctl) | Observationtime | DFS Tx vs Ctl | OS Tx vs Ctl | Conclusions |
| Lopez-Ladron et al[24] | Surgery+post-operative | 38 (28/10) | Median 15 | Median 15 vs 9 | Median 30vs15 | Not beneficial, |
| chemotherapy vs surgery alone | (mo) | (mo) (P = 0.352) | (mo) (P = 0.066) | needing further study | ||
| Portier et al[23] | Surgery+post-operative | 162 (81/81) | 5 yr | 5-yr 33% vs 24% | 5-yr 51% vs 44% | |
| chemotherapy (FU/FA) vs surgery alone | (P > 0.05) | (P > 0.05) | Not beneficial |
- Citation: Wang P, Chen Z, Huang WX, Liu LM. Current preventive treatment for recurrence after curative hepatectomy for liver metastases of colorectal carcinoma: A literature review of randomized control trials. World J Gastroenterol 2005; 11(25): 3817-3822
- URL: https://www.wjgnet.com/1007-9327/full/v11/i25/3817.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i25.3817